Fig. 2From: Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groupsDistribution of continuous KI67 scores according to categories of other clinical and pathological variables. Significant differences were seen in the distribution of automated KI67 scores according to categories of histological grade, tumour size, morphology, ER status, PR status and HER2 status, but not nodal status or stage. ER oestrogen receptor, HER2 human epidermal growth factor receptor 2, PR progesterone receptorBack to article page